STOCK TITAN

[Form 4] ORACLE CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Michael D. Sicilia, listed as Chief Executive Officer, reported the acquisition of a large stock option award in Oracle Corporation (ORCL). The Form 4 shows a derivative transaction dated 09/24/2025 in which 1,037,412 stock options were acquired with an exercise (conversion) price of $308.46. The filing reports the options as directly beneficially owned following the transaction.

The options have an exercisable/expiration date entry of 09/24/2035 and the form states that 25% of the shares subject to the option vest annually on each anniversary of the grant date. The form is signed by an attorney-in-fact, Aimee Weast, under power of attorney dated 06/12/2025, with signature dated 09/26/2025.

Michael D. Sicilia, indicato come Amministratore Delegato, ha riportato l'acquisizione di una cospicua stock option award in Oracle Corporation (ORCL). Il Modulo 4 mostra una transazione derivata datata 24/09/2025 in cui sono state acquisite 1.037.412 opzioni su azioni con un prezzo di esercizio di 308,46 USD. La dichiarazione riporta le opzioni come proprietà direttamente beneficiaria a seguito della transazione.

La voce di data di esercizio/scadenza delle opzioni è 24/09/2035 e il modulo indica che il 25% delle azioni soggette all'opzione maturano diritti con l' anniversario del grant. Il modulo è firmato da un procuratore, Aimee Weast, in base a procura datata 12/06/2025, con firma datata 26/09/2025.

Michael D. Sicilia, listado como Director Ejecutivo, informó la adquisición de una importante adjudicación de opciones sobre acciones en Oracle Corporation (ORCL). El Formulario 4 muestra una operación derivada fechada 24/09/2025 en la que se adquirieron 1.037.412 opciones sobre acciones con un precio de ejercicio de $308,46. La declaración reporta las opciones como propiedades directamente beneficiosas tras la transacción.

Las opciones tienen una fecha de exercisable/expiración de 24/09/2035 y el formulario indica que el 25% de las acciones sujetas a la opción se consolidan cada aniversario de la fecha de concesión. El formulario está firmado por un apoderado, Aimee Weast, bajo poder del 12/06/2025, con firma fechada 26/09/2025.

Michael D. Sicilia, 최고경영자로 기재되어 있으며 Oracle Corporation(ORCL)에서 대규모 주식매수선택권 수여를 취득했다. Form 4는 2025년 9월 24일자로 기원한 파생거래를 보여주며, 주식매수선택권 1,037,412주행사가격 308.46달러로 취득되었다. 제출서는 거래 후 해당 옵션을 직접적으로 유익하게 보유하고 있음을 보고한다.

옵션의 행사/만료 날짜는 2035년 9월 24일이고, 양식에는 옵션 대상 주식의 25%가 매년 수여일 기념일에 vest된다고 명시되어 있다. 이 양식은 Aimee Weast라는 대리인 아래 2025년 6월 12일에 발령된 위임장에 따라 서명되었으며, 서명일은 2025년 9월 26일이다.

Michael D. Sicilia, nommé Président-Directeur Général, a signalé l'acquisition d'une importante attribution d'options d'achat d'actions chez Oracle Corporation (ORCL). Le Formulaire 4 montre une transaction dérivée datée du 24/09/2025 au cours de laquelle 1 037 412 options sur actions ont été acquises avec un prix d'exercice de 308,46 USD. Le dépôt indique que les options sont propriétés bénéficiaires directes à la suite de la transaction.

Les options ont une date d'exercice/expiration du 24/09/2035 et le formulaire indique que 25% des actions soumises à l'option se vestent chaque année à la date anniversaire de la remise. Le formulaire est signé par un mandataire, Aimee Weast, en vertu d'une procuration datée du 12/06/2025, avec une signature datée du 26/09/2025.

Michael D. Sicilia, der als Chief Executive Officer geführt wird, meldete den Erwerb einer großen Anzahl von Aktienoptionszusagen bei Oracle Corporation (ORCL). Das Formular 4 zeigt eine derivativ Transaktion mit Datum 24.09.2025, bei der 1.037.412 Aktienoptionen zu einem Ausübungspreis von 308,46 USD erworben wurden. Die Einreichung berichtet, dass die Optionen nach der Transaktion als direkt vorteilhaft besessen gelten.

Die Optionen haben ein Ausübungs-/Verfallsdatum von 24.09.2035 und im Formular steht, dass 25% der Aktien, die unter der Option stehen, jährlich am Jahrestag des Gewährungstags vesten (vesting). Das Formular ist von einem Bevollmächtigten unterzeichnet, Aimee Weast, gemäß einer Vollmacht vom 12.06.2025 mit Unterschrift am 26.09.2025.

Michael D. Sicilia، المذكور كالرئيس التنفيذي، أبلغ عن اكتساب جائزة كبيرة من خيارات الأسهم في Oracle Corporation (ORCL). يبين النموذج 4 معاملة مشتقة بتاريخ 24/09/2025 حيث تم شراء 1,037,412 خياراً للسهم بسعر ممارسة قدره 308.46 دولار أمريكي. وتفيد الإيداع بأن الخيارات مملوكة مباشرةً لصالحه بعد المعاملة.

لدى الخيارات تاريخ قابلية/انتهاء اعتباراً من 24/09/2035 ويذكر النموذج أن 25% من الأسهم الخاضعة للخيار تتجسد سنوياً في كل ذكرى للمنحة. كان النموذج موقّعاً بواسطة وكيل، Aimee Weast، بموجب توكيل dated 12/06/2025، مع توقيع بتاريخ 26/09/2025.

迈克尔·D·西西利亚,列为首席执行官,报告在 Oracle Corporation(ORCL)获得大额股票期权奖励的情况。 Form 4 显示日期为 2025-09-24 的衍生交易,其中 1,037,412份股票期权以行权价 308.46 美元被取得。该备案在交易后将这些期权列为 直接受益所有

期权的可行/到期日期为 2035-09-24,表格还指出 在授予日的每个周年时,期权所覆盖的股票将有 25% vest。该表格由代理人 Aimee Weast 根据日期为 2025-06-12 的授权书签署,签名日期为 2025-09-26。

Positive
  • Large, disclosed award: The filing explicitly reports acquisition of 1,037,412 stock options, providing transparency on executive compensation.
  • Clear vesting schedule: The Form 4 states 25% vests annually, giving investors explicit timing of when options become exercisable.
Negative
  • None.

Insights

TL;DR: CEO received a sizable long-dated option grant of 1,037,412 options at $308.46 with standard annual vesting.

The Form 4 documents a single reporting-person filing by Michael D. Sicilia showing acquisition (code A) of 1,037,412 stock options on 09/24/2025 at a stated conversion price of $308.46. The disclosure that 25% vests each anniversary indicates a four-year vesting schedule beginning at grant. The options are recorded as directly beneficially owned and have an exercisable/expiration date noted as 09/24/2035, implying a long option term as disclosed. The filing was executed via power of attorney, which is properly noted on the form.

TL;DR: A large option award was granted to the CEO with multi-year vesting and a $308.46 strike, consistent with executive compensation disclosures.

The reported derivative transaction shows acquisition of 1,037,412 options with a conversion price of $308.46 and annual 25% vesting, which is a common structure for executive equity incentives. The option details (amount, price, vesting cadence, and long dated exercisability entry) are explicitly stated on the Form 4 and permit stakeholders to model potential future dilution and cost when combined with company disclosures elsewhere.

Michael D. Sicilia, indicato come Amministratore Delegato, ha riportato l'acquisizione di una cospicua stock option award in Oracle Corporation (ORCL). Il Modulo 4 mostra una transazione derivata datata 24/09/2025 in cui sono state acquisite 1.037.412 opzioni su azioni con un prezzo di esercizio di 308,46 USD. La dichiarazione riporta le opzioni come proprietà direttamente beneficiaria a seguito della transazione.

La voce di data di esercizio/scadenza delle opzioni è 24/09/2035 e il modulo indica che il 25% delle azioni soggette all'opzione maturano diritti con l' anniversario del grant. Il modulo è firmato da un procuratore, Aimee Weast, in base a procura datata 12/06/2025, con firma datata 26/09/2025.

Michael D. Sicilia, listado como Director Ejecutivo, informó la adquisición de una importante adjudicación de opciones sobre acciones en Oracle Corporation (ORCL). El Formulario 4 muestra una operación derivada fechada 24/09/2025 en la que se adquirieron 1.037.412 opciones sobre acciones con un precio de ejercicio de $308,46. La declaración reporta las opciones como propiedades directamente beneficiosas tras la transacción.

Las opciones tienen una fecha de exercisable/expiración de 24/09/2035 y el formulario indica que el 25% de las acciones sujetas a la opción se consolidan cada aniversario de la fecha de concesión. El formulario está firmado por un apoderado, Aimee Weast, bajo poder del 12/06/2025, con firma fechada 26/09/2025.

Michael D. Sicilia, 최고경영자로 기재되어 있으며 Oracle Corporation(ORCL)에서 대규모 주식매수선택권 수여를 취득했다. Form 4는 2025년 9월 24일자로 기원한 파생거래를 보여주며, 주식매수선택권 1,037,412주행사가격 308.46달러로 취득되었다. 제출서는 거래 후 해당 옵션을 직접적으로 유익하게 보유하고 있음을 보고한다.

옵션의 행사/만료 날짜는 2035년 9월 24일이고, 양식에는 옵션 대상 주식의 25%가 매년 수여일 기념일에 vest된다고 명시되어 있다. 이 양식은 Aimee Weast라는 대리인 아래 2025년 6월 12일에 발령된 위임장에 따라 서명되었으며, 서명일은 2025년 9월 26일이다.

Michael D. Sicilia, nommé Président-Directeur Général, a signalé l'acquisition d'une importante attribution d'options d'achat d'actions chez Oracle Corporation (ORCL). Le Formulaire 4 montre une transaction dérivée datée du 24/09/2025 au cours de laquelle 1 037 412 options sur actions ont été acquises avec un prix d'exercice de 308,46 USD. Le dépôt indique que les options sont propriétés bénéficiaires directes à la suite de la transaction.

Les options ont une date d'exercice/expiration du 24/09/2035 et le formulaire indique que 25% des actions soumises à l'option se vestent chaque année à la date anniversaire de la remise. Le formulaire est signé par un mandataire, Aimee Weast, en vertu d'une procuration datée du 12/06/2025, avec une signature datée du 26/09/2025.

Michael D. Sicilia, der als Chief Executive Officer geführt wird, meldete den Erwerb einer großen Anzahl von Aktienoptionszusagen bei Oracle Corporation (ORCL). Das Formular 4 zeigt eine derivativ Transaktion mit Datum 24.09.2025, bei der 1.037.412 Aktienoptionen zu einem Ausübungspreis von 308,46 USD erworben wurden. Die Einreichung berichtet, dass die Optionen nach der Transaktion als direkt vorteilhaft besessen gelten.

Die Optionen haben ein Ausübungs-/Verfallsdatum von 24.09.2035 und im Formular steht, dass 25% der Aktien, die unter der Option stehen, jährlich am Jahrestag des Gewährungstags vesten (vesting). Das Formular ist von einem Bevollmächtigten unterzeichnet, Aimee Weast, gemäß einer Vollmacht vom 12.06.2025 mit Unterschrift am 26.09.2025.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Sicilia Michael D.

(Last) (First) (Middle)
C/O DELPHI ASSET MGMT CORPORATION
200S.VIRGINIA ST., SUITE 625

(Street)
RENO NV 89501

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ORACLE CORP [ ORCL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $308.46 09/24/2025 A 1,037,412 (1) 09/24/2035 Common Stock 1,037,412 $0 1,037,412 D
Explanation of Responses:
1. 25% of the shares subject to the option vest annually on each anniversary of the grant date.
/s/ Aimee Weast by Aimee Weast, Attorney in Fact for Michael D. Sicilia (POA filed 6/12/2025) 09/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Michael D. Sicilia report for ORCL?

The Form 4 reports acquisition of 1,037,412 stock options on 09/24/2025 with a conversion price of $308.46.

What is the vesting schedule for the options reported on ORCL Form 4?

The filing states that 25% of the shares subject to the option vest annually on each anniversary of the grant date.

Are the reported options directly or indirectly owned?

The Form 4 lists the options as direct (D), with 1,037,412 options beneficially owned following the transaction.

When is the option exercisable or expiring according to the filing?

The Form 4 shows an exercisable/expiration date entry of 09/24/2035 for the reported derivative security.

Who signed the Form 4 for Michael D. Sicilia?

The form is signed by Aimee Weast as attorney-in-fact under a power of attorney dated 06/12/2025, with signature dated 09/26/2025.
Oracle Corp

NYSE:ORCL

ORCL Rankings

ORCL Latest News

ORCL Latest SEC Filings

ORCL Stock Data

806.09B
1.68B
41.55%
45.19%
0.76%
Software - Infrastructure
Services-prepackaged Software
Link
United States
AUSTIN